These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7691894)

  • 1. Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis.
    Edwards BD; Andrew SM; O'Driscoll JB; Chalmers RJ; Ballardie FW; Freemont AJ
    J Clin Pathol; 1993 Aug; 46(8):713-7. PubMed ID: 7691894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in T-cell phenotype and adhesion molecules expression in psoriatic lesions after low-dose cyclosporin therapy.
    Servitje O; Bordas X; Serón D; Vidaller A; Moreno A; Curcó N; Sais G; Peyrí J
    J Cutan Pathol; 1996 Oct; 23(5):431-6. PubMed ID: 8915851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M; Gül M; Seyhan M
    Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical studies of infiltrating cells in early and chronic lesions of psoriasis.
    Onuma S
    J Dermatol; 1994 Apr; 21(4):223-32. PubMed ID: 7914525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A.
    Horrocks C; Duncan JI; Oliver AM; Thomson AW
    Clin Exp Immunol; 1991 Apr; 84(1):157-62. PubMed ID: 2015706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation of psoriasis with a topical cyclosporin A formulation.
    Duncan JI; Wakeel RA; Winfield AJ; Ormerod AD; Thomson AW
    Acta Derm Venereol; 1993 Apr; 73(2):84-7. PubMed ID: 8103272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy.
    Thomson AW; Nalesnik MA; Rilo HR; Woo J; Carroll PB; Van Thiel DH
    Autoimmunity; 1993; 15(3):215-23. PubMed ID: 7505632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mometasone furoate decreases adhesion molecule expression in psoriasis.
    Berti E; Cerri A; Marzano AV; Richelda R; Bianchi B; Caputo R
    Eur J Dermatol; 1998 Sep; 8(6):421-6. PubMed ID: 9729054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.
    Van Riet I; De Waele M; Remels L; Lacor P; Schots R; Van Camp B
    Br J Haematol; 1991 Nov; 79(3):421-7. PubMed ID: 1721526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins.
    McGregor JM; Barker JN; Ross EL; MacDonald DM
    J Am Acad Dermatol; 1992 Sep; 27(3):383-8. PubMed ID: 1401271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A rapidly inhibits epidermal cytokine expression in psoriasis lesions, but not in cytokine-stimulated cultured keratinocytes.
    Elder JT; Hammerberg C; Cooper KD; Kojima T; Nair RP; Ellis CN; Voorhees JJ
    J Invest Dermatol; 1993 Dec; 101(6):761-6. PubMed ID: 8245502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclosporin A on resident and passenger immune cells of normal human skin and UV-induced erythema reactions.
    Petzelbauer P; Wolff K
    Br J Dermatol; 1992 Dec; 127(6):560-5. PubMed ID: 1362075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-CD4 monoclonal antibody therapy in severe psoriasis.
    Morel P; Revillard JP; Nicolas JF; Wijdenes J; Rizova H; Thivolet J
    J Autoimmun; 1992 Aug; 5(4):465-77. PubMed ID: 1384529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of psoriasis to a new topical retinoid, AGN 190168.
    Esgleyes-Ribot T; Chandraratna RA; Lew-Kaya DA; Sefton J; Duvic M
    J Am Acad Dermatol; 1994 Apr; 30(4):581-90. PubMed ID: 7512583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 antibody therapy and cyclosporin A differentially affect HLA-DR and ICAM-1 expression in psoriatic skin.
    Nicolas JF; Rizova H; Demidem A; Thivolet J; Morel P; Revillard JP
    J Invest Dermatol; 1992 Jun; 98(6):943-4. PubMed ID: 1350608
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in numbers of epidermal cell adhesion molecules caused by oral cyclosporin in psoriasis.
    Payne FB; Jones L; De Haro T; Fletcher A; Hutchinson P
    J Clin Pathol; 1994 Jan; 47(1):95. PubMed ID: 7907611
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment.
    Gerritsen MJ; Rulo HF; Arnold WP; Van de Kerkhof PC
    Br J Dermatol; 1994 Feb; 130(2):181-8. PubMed ID: 7510122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis.
    Gottlieb A; Krueger JG; Bright R; Ling M; Lebwohl M; Kang S; Feldman S; Spellman M; Wittkowski K; Ochs HD; Jardieu P; Bauer R; White M; Dedrick R; Garovoy M
    J Am Acad Dermatol; 2000 Mar; 42(3):428-35. PubMed ID: 10688712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments.
    Danno K; Kaji A; Mochizuki T
    J Dermatol Sci; 1996 Oct; 13(1):49-55. PubMed ID: 8902653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacious treatment of psoriasis with low-dose and intermittent cyclosporin microemulsion therapy.
    Ito T; Furukawa F; Iwatsuki K; Matsue H; Shimada S; Takigawa M; Tokura Y
    J Dermatol; 2014 May; 41(5):377-81. PubMed ID: 24628433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.